Sex differences in the pharmacological treatment of hypertension: A review of population-based studies

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 591-600

  Klungel, Olaf H ^a   De Boer, Anthonius ^a   Paes, Arsenio H P ^a   Seidell, Jacob C ^b   Bakker, Albert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Antihypertensive drug use; Hypertension; Pharmacological treatment; Review; Sex differences

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO;

EID: 0031008498     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00004     Document Type: Article

References (77)

1. The Principal Investigations of the MONICA Project: WHO MONICA Project: geographic variation in mortality from cardiovascular diseases - baseline data on selected population characteristics and cardiovascular mortality. World Health Statist Quart 1987, 40:171-184.
2. Uemura K, Pisa Z: Recent trends in cardiovascular disease mortality in 27 industrialized countries. World Health Statist Quart 1985, 38:142-162.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
4. Fiebach NH, Hebert PR, Stampfer MJ, Colditz GA, Willett WC, Rosner B: A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989, 130:646-654.
5. Sigurdsson JA, Bengtsson C, Lapidus L, Lindquist O, Rafnsson V: Morbidity and mortality in relation to blood pressure and antihypertensive treatment: a 12-year follow-up study of a population sample of Swedish women. Acta Med Scand 1984, 215:313-322.
6. Johnson JL, Heinemann EF, Heiss G, Harnes CG, Tyroler HA: Cardiovascular disease risk factors and mortality among black women and white women aged 40-64 years in Evans County, Georgia. Am J Epidemiol 1986, 123:209-220.
7. Stamler J, Stamler S, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153:598-615.
8. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham study. Am J Cardiol 1976, 38:46-51.
9. MacMahon S, Collins R: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994, 50:272-298.
10. Hoes AW, Grobbee DE, Lubsen J: Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens 1995, 13:805-811.
11. Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, et al.: Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of The Society of General Internal Medicine. Ann Intern Med 1991, 115:287-293.
12. Egger M, Smith GD: Risks and benefits of treating mild hypertension: a misleading meta-analysis? J Hypertens 1995, 3:813-815.
13. Jackson R, Barham P, Bills J, McLennan L, MacMahon S, Maling T: Management of raised blood pressure in New Zealand: a discussion document BMJ 1993, 307:107-110.
14. Whelton PK: Epidemiology of hypertension. Lancet 1994, 344: 101-106.
15. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154-183.
16. Greenland S, Robins JM: Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985, 41:55-68.
17. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H: Control of blood pressure in Scotland. The rule of halves. BMJ 1990, 300:981-983.
18. The WHO MONICA Project: Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Statist Quart 1988, 41:115-139.
19. Shelley E, Daly L, Collins C, Christie M, Conroy R, Gibney M, et al.: Cardiovascular risk factor changes in the Kilkenny Health Project. A community health promotion programme. Eur Heart J 1995, 16:752-760.
20. Vez{{ü}} L, La Vecchia L, Vincenzi M: Hypertension, obesity and response to antihypertensive treatment: results of a community survey. J Hum Hypertens 1992, 6:215-220.
21. Laurenzi M, Cirillo M, Trevisan M: The Gubbio data. Epidemiology and pathophysiology. Clin Exp Hypertens 1992, 14:261-269.
22. Jackson RT, Beaglehole R, Stewart AW: Blood pressure levels and the treatment of hypertension in Auckland 1982. NZ Med J 1983, 96:751-754.
23. Jackson R, Beaglehole R, Yee RL, Small C, Scragg R: Trends in cardiovascular risk factors in Auckland, 1982 to 1987. NZ Med J 1990 103:363-365.
24. van Leer EM, Verschuren WMM, Kromhout D: Trends in blood pressure and prevalence and treatment of hypertension in young adults in The Netherlands 1974-1986. Eur J Epidermiol 1994, 10:151-158.
25. Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, et al.: Cardiovascular disease risk factors in The Netherlands. Neth J Cardiol 1993, 6:205-210.
26. Verschuren WMM, Smit HA, van Leer EM, Berns MPH, Blokstra A, Steenbrink-van Woerden JA, et al.: Prevalence of and Changes in Cardiovascular Risk Factors in the Period 1987-1991. Final Report of the Monitoring Project on Cardiovascular Disease Risk Factors [in Dutch]. Report 528901.011. Bilthoven: RIVM; 1994.
27. Schuurman FH: A Method for Tracing and Treatment of Hypertension in General Practice. The Groningen Hypertension Service [Thesis, in Dutch], Groningen: University of Groningen; 1985.
28. van Ree JW: Het Niimeegs Interventie Project [Thesis]. Nijmegen: Katholieke Universiteit Nijmegen; 1981.
29. Keil U, Remmers A, Chambless L, Hense HW, Stieber J, Lauck A: Epidemiologie des Bluthochdruckes, Häufigkeit, Verteilung, Bekanntheits- und Behandlungsgrad der Hypertonie in der Hansestadt Lübeck. Ergebnisse der Lübecker Blutdruckstudie und Vergleich mit Daten der Münchener Blutdruckstudie. Münch Med Wochenschr 1986, 128:424-429.
30. Heinemann LAJ, Greiser EM: Blood pressure, hypertension and other risk factors in east and west Germany. Ann Epidemiol 1993, 3 (5 suppl 1):S90-S95.
31. Helmert U, Herman B, Klesse R, Greiser E: Prävalenz und Behandlungsstatus des Bluthochdruckes - Ergebnisse des 1. Bremer DHP-Gesundheitssurveys. Offent Gesundheit Wes 1987, 49:621-627.
32. Hense HW, Stieber J, Filipiak B, Keil U: Five-year changes in population blood pressure and hypertension prevalence. Results from the MONICA Augsburg Surveys 1984/85 and 1989/90. Ann Epidemiol 1993, 3:410-416.
33. Stieber J, Döring A, Keil U: Häufigkeit, Bekanntheits- und Behandlungsgrad der Hypertonie in einer Gro{{B}}stadtbevölkerung. Ergebnisse der Münchner Blutdruck-Studie I. Münch Med Wochenschr 1982, 124:747-752.
34. Heinemann L, Heine H, Assmann A, Schadlich H, Barth W, Thiel C, et al.: Risk factors in the population of the GDR-MONICA study (1983/84). Acta Med Scand Suppl 1988, 728:144-149.
35. Tuomilehto J, Nissinen A, Wolf E, Geboers J, Piha T, Puska P: Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community. BMJ 1985, 291:857-861.
36. Enlund H, Nissinen A, Tuomilehto J: Antihypertensive drug treatment in a middle-aged population. Hypertension 1982, 4:716-724.
37. Salomaa V, Tuomilehto J, Kartovaara L, Marti B, Nissinen A, Korhonen HJ, et al.: Trends in cardiovascular risk factors in treated and untreated hypertensive and normotensive Finnish subjects 1982-1987. Rev Epidém Santé Publ 1990, 38:493-500.
38. Ohmori S, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al.: Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study. J Hypertens 1994, 12:1191-1197.
39. Huhtasaari F, Asplund K. Wester PO: Cardiovascular risk factors in the Northern Sweden MONICA Study. Acta Med Scand 1988, 224: 99-108.
40. MacMahon SW, Blacket RB, Macdonald GJ, Hall W: Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens 1984, 2:85-91.
41. Labarthe DR, Krishan I, Nobrega FT, Brennan LA, Smoldt RK, Mon HD, et al.: The Mayo Three-Community Hypertension Control Program. I. Design and initial screening results. Mayo Clin Proc 1979, 54: 289-298.
42. Pappas G, Gergen PJ, Carroll M: Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic Health and Nutrition Examination Survey (HHANES), 1982-84. Am J Public Health 1990, 80:1431-1436.
43. Stern MP, Gaskill SP, Allen CR, Garza V, Gonzales JL Waldrop RH: Cardiovascular risk factors in Mexican Americans in Laredo, Texas. II. Prevalence and control of hypertension. Am J Epidemiol 1981, 113:556-562.
44. Haffner SM, Mitchell BD, Stern MP, Hazuda HP, Patterson JK: Decreased prevalence of hypertension in Mexican-Americans. Hypertension 1990, 16:225-232.
45. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al.: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995, 26:60-69.
46. Sprafka JM, Burke GL, Folsom AR, Luepker RV, Blackburn H: Continued decline in cardiovascular disease risk factors. Results of the Minnesota heart survey 1980-1982 and 1985-1987. Am J Epidemiol 1990, 132:489-500.
47. Folmson AR, Luepker RV, Gillum RF, Jacobs DR, Prineas RJ, Taylor HL, et al.: Improvement in hypertension detection and control from 1973-1974 to 1980-1981. The Minnesota heart survey experience. JAMA 1983, 250:916-921.
48. Apostolides AY, Cutter G, Kraus JF, Oberman A, Blaszkowski T, Brohani NO, et al.: Impact of hypertension information on high blood pressure control between 1973 and 1978. Hypertension 1980, 2:708-713.
49. Stamler J, Stamler S, Riedlinger WF, Algera G, Roberts RH: Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973 through 1975. JAMA 1976, 235:2299-2306.
50. Wagner EH, James SA, Beresford SAA, Strogatz DS, Grimson RC, Kleinbaum DG, et al.: The Edgecombe County High Blood Pressure Control Program: I. Correlates of uncontrolled hypertension at baseline. Am J Public Health 1984, 74:237-242.
51. Entwisle G, Scott JC, Apostolides AY, Southard J, Su S, Brandon B, et al.: A survey of blood pressure in the state of Maryland. Prev Med 1983, 12:695-708.
52. Plans P, Pardell H, Salleras L: Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993, 9:381-389.
53. Brohet C, Janssens D, Beck D, Hannut R, Kulbertus H, Lavenne F, et al.: Cardiovascular risk factors in a sample of a rural Belgian population. The Bellux MONICA study. Acta Med Scand Suppl 1988, 728:129-136.
54. Enlund H, Turakka H, Tuomilehto J: Combination therapy in hypertension. A population-based study in eastern Finland. Eur J Clin Pharmacol 1981, 21:1-8.
55. Nissinen A, Tuomilehto J, Pekkanen J, Enlund H, Gunther A: Drug treatment of high blood pressure in the community - experience in eastern Finland. J Hum Hypertens 1989, 3:165-171.
56. Baksaas I, Fugelli P, Halvorsen IK, Lunde PKM, Naess K: Prescription of hypotensives in general practice: a study of 4 Norwegian counties in October 1975. Eur J Clin Pharmacol 1978, 14:309-317.
57. Nilsson P, Andersson DKG, Andersson PE, Schwan A, Ostlind B, Malmborg R, et al.: Cardiovascular risk factors in treated hypertensives - a nation-wide, cross-sectional study in Sweden. J Intern Med 1993, 233:239-245.
58. Psaty BM, Savage PJ, Tell GS, Polak JF, Hirsch CH, Gardin CH, et al.: Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA 1993, 270:1837-1841.
59. Hense HW, Döring A, Stieber J, Keil U: The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies. J Clin Epidemiol 1992, 45:1243-1430.
60. Wenger NK, Speroff L, Packard B: Cardiovascular health and disease in women. N Engl J Med 1993, 329:247-256.
61. Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, et al.: Gender differences in the management of coronary artery disease. N Engl J Med 1991, 325:226-230.
62. Reeves RA: Does this patient have hypertension? How to measure blood pressure. JAMA 1995, 273:1211-1218.
63. Bennett S: Blood pressure measurement error: its effect on cross-sectional and trend analyses. J Clin Epidemiol 1994, 47:293-301.
64. Guibert R, Franco ED: Choosing a definition of hypertension: impact on epidemiological estimates. J Hypertens 1996, 14:1275-1280.
65. Vaccarino V, Borgatta A, Gallus G, Sirtori R: Prevalence of coronary heart disease risk factors in northern-Italian male and female employees. Eur Heart J 1995, 16:761-769.
66. Green MS, Peled I: Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985-1987: the Cordis study. Int J Epidemiol 1992, 21:676-682.
67. Marcus AC, Siegel JM: Gender differences in the use of physician services. J Health Soc Behav 1982, 23:186-197.
68. Waldron I: Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med 1983, 17:1107-1123.
69. MacMahon S: Guidelines for antihypertensive therapy. J Hypertens 1996, 14:691-693.
70. Johansson S, Vedin A, Wilhelmsson C: Myocardial infarction in women. Epidemiol Rev 1983, 5:67-95.
71. Williams EL, Winkleby MA, Fortmann SP: Changes in coronary heart disease risk factors in the 1980s: evidence of a male-female crossover effect with age. Am J Epidemiol 1993, 137:1056-1067.
72. Verschuren WM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, et al.: Cardiovascular disease risk factors in The Netherlands. Neth J Cardiol 1993, 6:205-210.
73. Hofman A, Grobbee DE, de Jong PTVM, van Ouweland FA: Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991, 7:403-422.
74. Bolli P, Bühler FR: Risk and risk minimization of drug-induced adversity in hypertension. Progr Pharmacol 1985, 6:1-16.
75. Brock GB, Lue TF: Drug-induced male sexual dysfunction. An update. Drug Safety 1993, 8:414-426.
76. Visser LE, Stricker BHCh, van der Velden J, Paes AHP, Bakker A: Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol 1995, 48:851-857.
77. MRC Working Party: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 2:97-104.